Clin2
NCT03866408Possibly a fitRecruiting

Testing how insulin affects fat breakdown proteins

Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This early study looks at how insulin changes the body’s fat breakdown and related proteins. You might join if you’re within a certain body-weight range and can safely take the study medication.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
64 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are age 18 to 55
  • If you are a woman, you are not through menopause yet
  • Your body weight fits one of these ranges: BMI 18 to 25, or BMI 30 to 38
  • You do not have severe heart failure symptoms (NYHA class III or IV)
  • You are not allergic to pioglitazone (Actos) or its ingredients

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06392854Recruiting· Early Phase 1
Fat tissue and insulin in obesity

This early-phase trial tests how fat tissue in different parts of the body responds to insulin. It may help researchers understand why some people with obesity are more prone to health problems like diabetes or heart disease.

Rochester, Minnesota
NCT06416969Recruiting· Early Phase 1
Study of fat breakdown in overweight adults

This study looks at how fat cells in the belly release fat. Researchers want to learn more about fat breakdown in people who are overweight or obese. If you join, you may get a drug that helps them measure fat activity.

Rochester, Minnesota
NCT06129110Recruiting
Weight loss and muscle fat study for adults aged 18-70

This study looks at how losing weight affects the fat that sits inside your muscles (called intermuscular fat). It might help people with overweight to better understand how weight loss can improve muscle health.

Aurora, Colorado
NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT06335771Recruiting
Study on fat metabolism in obesity and diabetes

This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.

Columbia, Missouri
NCT05933707Recruiting
Study tiny vesicles and how they affect insulin

This study looks at how very small particles in the body (“extracellular vesicles”) relate to insulin action and how the body handles sugar. It may help researchers understand why some people have better or worse insulin responses.

St Louis, Missouri

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.